Novartis AG

1. 01

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $164.98 was 11.0% above its 50-day average ($148.58) and 8.5% above its 200-day average ($152.08). It has closed above the 200-day for 8 sessions, since 26 Oct 2026. The 50-day average crossed below the 200-day on 2 Oct 2026, 23 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

2. 02

   3.2% below its 52-week high

   Closed at $164.98 on 4 Nov 2026: 3.2% below the 52-week high of $170.46 (27 Feb 2026) and 33.9% above the low of $123.24 (20 Nov 2025).

   Daily price bars, split-adjusted · as of 4 Nov 2026

3. 03

   RSI(14) at 70.5, 70 or above

   The 14-session relative strength index closed at 70.5 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.

   Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

4. 04

   Short interest at 0.3% of shares outstanding

   5.6M shares were sold short at the 15 Oct 2026 settlement, 0.3% of the 2.03B shares outstanding; covering them would take 3.2 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close